Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

Similar articles for PubMed (Select 21502695)

1.

[Influence of different physical conditions on HIV infectivity].

Gąsiorowski J, Łapiński Ł, Knysz B.

Postepy Hig Med Dosw (Online). 2011 Mar 25;65:190-4. Polish.

2.

HIV-associated nephropathy: experimental models.

Avila-Casado C, Fortoul TI, Chugh SS.

Contrib Nephrol. 2011;169:270-85. doi: 10.1159/000320212. Epub 2011 Jan 20.

PMID:
21252526
4.

Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivation.

Sheng-Fowler L, Lewis AM Jr, Peden K.

Biologicals. 2009 Aug;37(4):259-69. doi: 10.1016/j.biologicals.2009.04.002. Epub 2009 May 19.

PMID:
19457682
5.

Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.

Matsuoka S, Dam E, Lecossier D, Clavel F, Hance AJ.

Retrovirology. 2009 Mar 2;6:21. doi: 10.1186/1742-4690-6-21.

6.

Oligonucleotide-mediated retroviral RNase H activation leads to reduced HIV-1 titer in patient-derived plasma.

Heinrich J, Mathur S, Matskevich AA, Moelling K.

AIDS. 2009 Jan 14;23(2):213-21. doi: 10.1097/QAD.0b013e32831c5480.

PMID:
19098491
7.

HLA-C increases HIV-1 infectivity and is associated with gp120.

Matucci A, Rossolillo P, Baroni M, Siccardi AG, Beretta A, Zipeto D.

Retrovirology. 2008 Aug 1;5:68. doi: 10.1186/1742-4690-5-68.

8.

Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses.

Nora T, Bouchonnet F, Labrosse B, Charpentier C, Mammano F, Clavel F, Hance AJ.

Retrovirology. 2008 Feb 29;5:23. doi: 10.1186/1742-4690-5-23.

9.

Preventing sexual transmission of HIV.

Cohen MS.

Clin Infect Dis. 2007 Dec 15;45 Suppl 4:S287-92. doi: 10.1086/522552.

10.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
11.

Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures.

Tschochner M, Schwingel E, Thein C, Wittmann S, Paatz C, Walter H.

J Virol Methods. 2007 Apr;141(1):87-96. Epub 2006 Dec 28.

PMID:
17196267
12.

A unified concept of HIV latency.

Bagasra O.

Expert Opin Biol Ther. 2006 Nov;6(11):1135-49. Review.

PMID:
17049012
13.

[Inhibitory effect of human saliva on HIV-1 infectivity].

Etsuko K, Wei S.

Nihon Rinsho Meneki Gakkai Kaishi. 2001 Aug;24(4):152-9. Review. Japanese.

PMID:
16578966
14.

Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin.

Said EA, Courty J, Svab J, Delbé J, Krust B, Hovanessian AG.

FEBS J. 2005 Sep;272(18):4646-59.

16.

Viral infectivity is maintained by an RNA protection buffer.

Uhlenhaut C, Kracht M.

J Virol Methods. 2005 Sep;128(1-2):189-91.

PMID:
15936833
17.

Intermittent low-level viremia in very early primary HIV-1 infection.

Fiebig EW, Heldebrant CM, Smith RI, Conrad AJ, Delwart EL, Busch MP.

J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):133-7.

PMID:
15905727
18.

Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection.

Wei BL, Denton PW, O'Neill E, Luo T, Foster JL, Garcia JV.

J Virol. 2005 May;79(9):5705-12.

20.

Novel method of inactivation of human immunodeficiency virus type 1 by the freeze pressure generation method.

Otake T, Kawahata T, Mori H, Kojima Y, Hayakawa K.

Appl Microbiol Biotechnol. 2005 Jun;67(6):746-51. Epub 2005 Feb 8.

PMID:
15700126
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk